Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases Life Science
Calif ornia-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000 Cannabis, Life Science